Central venous access devices site care practices: An international survey of 34 countries

Journal of Vascular Access

Volumn 17, Issue 1, 2016, Pages 78-86

  Broadhurst, Daphne ^a   Moureau, Nancy ^b,c,d   Ullman, Amanda J ^d,e  

^a Pro Medical Pharmacy   (Canada)

^b Chief Executive Officer   (United States)

^c GREENVILLE HOSPITAL SYSTEM   (United States)

^d GRIFFITH UNIVERSITY   (Australia)

^e GRIFFITH UNIVERSITY   (Australia)

Author keywords

Central venous catheter; Dressing; Evidence based care; Site care; Skin impairment

Indexed keywords

ANTISEPSIS; ARTICLE; CENTRAL VENOUS ACCESS DEVICES SITE CARE PRACTICE; CLINICAL DECISION MAKING; CROSS-SECTIONAL STUDY; DEVICE SECUREMENT PRACTICE; DRESSING SELECTION; FEMALE; FREQUENCY OF DRESSING CHANGE; HEALTH CARE PRACTICE; HUMAN; MALE; MEDICAL PARAMETERS; MEDICAL PROCEDURES; RASH; SKIN STRIPPING; ADVERSE EFFECTS; BANDAGE; CATHETER-RELATED INFECTIONS; CENTRAL VENOUS CATHETER; CENTRAL VENOUS CATHETERIZATION; CLINICAL PRACTICE; DEVICES; EDUCATIONAL STATUS; HEALTH CARE DISPARITY; HEALTH CARE SURVEY; INDWELLING CATHETER; MICROBIOLOGY; PRACTICE GUIDELINE; PROTOCOL COMPLIANCE; SKIN; TRENDS;

ANTISEPSIS; BANDAGES; CATHETER-RELATED INFECTIONS; CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; CENTRAL VENOUS CATHETERS; CROSS-SECTIONAL STUDIES; EDUCATIONAL STATUS; FEMALE; GUIDELINE ADHERENCE; HEALTH CARE SURVEYS; HEALTHCARE DISPARITIES; HUMANS; MALE; PRACTICE GUIDELINES AS TOPIC; PRACTICE PATTERNS, PHYSICIANS'; SKIN;

EID: 84956875168     PISSN: 11297298     EISSN: 17246032     Source Type: Journal    
DOI: 10.5301/jva.5000450     Document Type: Article

References (39)

1. Pronovost P, Needham D, Berenholtz S, et al. An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med. 2006;355(26):2725-2732.
2. Ryder M. Evidence-based practice in the management of vascular access devices for home parenteral nutrition therapy. JPEN J Parenter Enteral Nutr. 2006;30(1)(Suppl):S82-S93, S98-S99.
3. Timsit JF, Mimoz O, Mourvillier B, et al. Randomized controlled trial of chlorhexidine dressing and highly adhesive dressing for preventing catheter-related infections in critically ill adults. Am J Respir Crit Care Med. 2012;186(12):1272-1278.
4. Ullman AJ, Cooke M, Rickard C. Examining the role of securement and dressing products to prevent central venous access device failure: a narrative review. J Assoc Vasc Access. 2015;20(2):99-110.
5. Ullman AJ, Long DA, Rickard CM. Prevention of central venous catheter infections: a survey of paediatric ICU nurses’ knowledge and practice. Nurse Educ Today. 2014;34(2):202-207.
6. Loveday HP, Wilson JA, Pratt RJ, et al; UK Department of Health. epic3: national evidence-based guidelines for preventing healthcare-associated infections in NHS hospitals in England. J Hosp Infect. 2014;86(Suppl 1):S1-S70.
7. O’Grady NP, Alexander M, Burns LA, et al; Healthcare Infection Control Practices Advisory Committee (HICPAC) (Appendix 1). Guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis. 2011;52(9):1087-1099.
8. Infusion Nurses Society. Infusion Nursing Standards of Practice. J Infus Nurs. 2006;29(1)(Suppl):S1-S92.
9. Royal College of Nursing. Standards for Infusion Therapy in the RCN IV Therapy Forum. London: Royal College of Nursing; 2010.
10. Intravenous Nursing New Zealand Inc. Infusion Therapy Standards of Practice, IVNNZ Inc., Editor. 2012: New Zealand.
11. Pittiruti M, Hamilton H, Biffi R, MacFie J, Pertkiewicz M; ESPEN. ESPEN Guidelines on Parenteral Nutrition: central venous cath eters (access, care, diagnosis and therapy of complications). Clin Nutr. 2009;28(4):365-377.
12. Al-Sayaghi KM. Management of central venous catheters at the intensive care units in Yemen. Survey of practices. Saudi Med J. 2011;32(3):275-282.
13. Bolz K, Ramritu P, Halton K, Cook D, Graves N. Management of central venous catheters in adult intensive care units in Australia: policies and practices. Health Infect. 2008;13(2):48-55.
14. Krein SL, Hofer TP, Kowalski CP, et al. Use of central venous catheter-related bloodstream infection prevention practices by US hospitals. Mayo Clin Proc. 2007;82(6):672-678.
15. Warren DK, Yokoe DS, Climo MW, et al. Preventing catheter-associated bloodstream infections: a survey of policies for insertion and care of central venous catheters from hospitals in the prevention epicenter program. Infect Control Hosp Epidemiol. 2006;27(1):8-13.
16. Rickard CM, Courtney M, Webster J. Central venous catheters: a survey of ICU practices. J Adv Nurs. 2004;48(3):247-256.
17. Rattray J, Jones MC. Essential elements of questionnaire design and development. J Clin Nurs. 2007;16(2):234-243.
18. Thayer D. Skin damage associated with intravenous therapy: common problems and strategies for prevention. J Infus Nurs. 2012;35(6):390-401.
19. Lynn MR. Determination and quantification of content validity. Nurs Res. 1986;35(6):382-385.
20. Bannigan K, Watson R. Reliability and validity in a nutshell. J Clin Nurs. 2009;18(23):3237-3243.
21. Fields A. Discovering statistics using SPSS. 2nd ed. London: SAGE Publications; 2009.
22. Arvaniti K, Lathyris D, Clouva-Molyvdas P, et al; Catheter-Related Infections in ICU (CRI-ICU) Group. Comparison of Oligon catheters and chlorhexidine-impregnated sponges with standard multilumen central venous catheters for prevention of associated colonization and infections in intensive care unit patients: a multicenter, randomized, controlled study. Crit Care Med. 2012;40(2):420-429.
23. Timsit JF, Schwebe C, Bouadma L, et al; Dressing Study Group. Chlorhexidine-impregnated sponges and less frequent dressing changes for prevention of catheter-related infections in critically ill adults: a randomized controlled trial. JAMA. 2009; 301(12):1231-1241.
24. Safdar N, O’Horo JC, Ghufran A, et al. Chlorhexidine-impregnated dressing for prevention of catheter-related bloodstream infection: a meta-analysis. Crit Care Med. 2014;42(7):1703-1713.
25. Moureau NL, Iannucci AL. Catheter securement: trends in performance and complications associated with the use of either traditional methods or an adhesive anchor device. J Vasc Access Devices. 2003;8(1):29-33.
26. Yamamoto AJ, Solomon JA, Soulen MC, et al. Sutureless securement device reduces complications of peripherally inserted central venous catheters. J Vasc Interv Radiol. 2002;13(1): 77-81.
27. Bausone-Gazda D, Lefaiver CA, Walters SA. A randomized controlled trial to compare the complications of 2 peripheral intravenous catheter-stabilization systems. J Infus Nurs. 2010; 33(6):371-384.
28. Flippo P, Lee J. Clinical evaluation of the Sorbaview SHIELD securement device used on peripheral intravenous catheters in the acute care setting. J Assoc Vasc Access. 2011;16(2):1-7.
29. Saijo F, Mutoh M, Kurihara M, et al. Effect of the sutureless stabilization device, SorbaView SHIELD, on the peripherally inserted central catheter. Jpn J Surg Metab Nutr. 2014;48(4):107-113.
30. Ingram P, Murdoch MF. Aseptic non-touch technique in intravenous therapy. Nurs Stand. 2009;24(8):49-57, quiz 58, 60.
31. Meier PA, Fredrickson M, Catney M, Nettleman MD. Impact of a dedicated intravenous therapy team on nosocomial bloodstream infection rates. Am J Infect Control. 1998;26(4): 388-392.
32. Miller PK. Downsizing. Use intravenous clinicians to maintain quality venous access care.J Intraven Nurs. 1998;21(2): 105-112.
33. Buggs C, Valadez AM, Lund CA. Evaluating the effectiveness of an intravenous therapy team. Nurs Econ. 1993;11(4):249-255.
34. Abi-Said D, Raad I, Umphrey J, et al. Infusion therapy team and dressing changes of central venous catheters. Infect Control Hosp Epidemiol. 1999;20(2):101-105.
35. McNichol L, Lund C, Rosen T, Gray M. Medical adhesives and patient safety: state of the science: consensus statements for the assessment, prevention, and treatment of adhesive-related skin injuries. Orthop Nurs. 2013;32(5):267-281.
36. Kutzscher L. Management of irritant contact dermatitis and peripherally inserted central catheters. Clin J Oncol Nurs. 2012; 16(2):E48-E55.
37. ©. Adv Skin Wound Care. 2011; 24 (9) (Suppl):2-15.
38. Blough L, Hinson K, Hen J. The science of a ‘seal’ for PICC line management: BioSeal CVC Powder. J Assoc Vasc Access. 2010;15(2): 66-73.
39. Schears G. Online surveys: a potential weapon against clinician non-compliance. J Assoc Vasc Access. 2012;17(1):38-41.